HomeCompareNBEV vs MRK

NBEV vs MRK: Dividend Comparison 2026

NBEV yields 2139.04% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 NBEV wins by $18612808245.12M in total portfolio value
10 years
NBEV
NBEV
● Live price
2139.04%
Share price
$0.09
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$18612808245.17M
Annual income
$17,045,253,038,760,802.00
Full NBEV calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — NBEV vs MRK

📍 NBEV pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodNBEVMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, NBEV + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
NBEV pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

NBEV
Annual income on $10K today (after 15% tax)
$181,818.18/yr
After 10yr DRIP, annual income (after tax)
$14,488,465,082,946,682.00/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, NBEV beats the other by $14,488,465,082,938,354.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of NBEV + MRK for your $10,000?

NBEV: 50%MRK: 50%
100% MRK50/50100% NBEV
Portfolio after 10yr
$9306404122.62M
Annual income
$8,522,626,519,385,300.00/yr
Blended yield
91.58%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

NBEV
Analyst Ratings
3
Buy
1
Hold
Consensus: Buy
Altman Z
0.8
Piotroski
2/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

NBEV buys
0
MRK buys
0
No recent congressional trades found for NBEV or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricNBEVMRK
Forward yield2139.04%2.76%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$18612808245.17M$56.8K
Annual income after 10y$17,045,253,038,760,802.00$9,798.13
Total dividends collected$18502108744.53M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusBuyBuy

Year-by-year: NBEV vs MRK ($10,000, DRIP)

YearNBEV PortfolioNBEV Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$224,604$213,903.74$11,206$366.19+$213.4KNBEV
2$4,730,380$4,490,054.34$12,650$502.35+$4.72MNBEV
3$93,440,061$88,378,553.90$14,407$694.19+$93.43MNBEV
4$1,731,530,027$1,631,549,161.58$16,585$967.82+$1731.51MNBEV
5$30,108,907,543$28,256,170,414.87$19,342$1,363.89+$30108.89MNBEV
6$491,408,722,683$459,192,191,611.37$22,913$1,947.19+$491408.70MNBEV
7$7,530,007,997,984$7,004,200,664,712.92$27,662$2,823.89+$7530007.97MNBEV
8$108,363,216,304,007$100,306,107,746,164.31$34,159$4,173.35+$108363216.27MNBEV
9$1,465,004,865,806,410$1,349,056,224,361,122.80$43,337$6,308.80+$1465004865.76MNBEV
10$18,612,808,245,173,660$17,045,253,038,760,802.00$56,776$9,798.13+$18612808245.12MNBEV

NBEV vs MRK: Complete Analysis 2026

NBEVStock

NewAge, Inc. develops, markets, sells, and distributes healthy products in the United States, Japan, China, and internationally. The company operates in two segments, Direct / Social Selling and Direct Store. It provides health and wellness, energy drink, essential oil and anti-aging skincare, cosmetic, beverage, snacks, water and air filtration, and personal care products, as well as weight management, nutritional supplement, nutraceutical, and slenderiize products; diagnostic products, such as DNA testing and diagnostic kits and products; and CBD products. The company offers its products under the Tahitian Noni, LIMU, Zennoa, LIMU Blue Frog, Hiro Natural, TeMana, Lucim, Reviive, Puritii, and MaVie brands. It sells its products directly to customers, as well as through distributors, e-commerce sites, and direct-store-delivery systems. The company was formerly known as New Age Beverages Corporation and changed its name to NewAge, Inc. in July 2020. NewAge, Inc. was incorporated in 2010 and is headquartered in Denver, Colorado. On August 30, 2022, NewAge, Inc. along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.

Full NBEV Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this NBEV vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

NBEV vs SCHDNBEV vs JEPINBEV vs ONBEV vs KONBEV vs MAINNBEV vs JNJNBEV vs ABBVNBEV vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.